Trial intelligence / Profile preview

Jinsang Liyan Capsules Combined With Proton Pump Inhibitors in the Treatment of Laryngeal Reflux Disease (LPRD)

NCT05879029Phase 4Recruiting

Sponsor
Tongji Hospital
Start
Jul 2023
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Jinsang Liyan Capsule in laryngopharyngeal reflux (LPR), sponsored by Tongji Hospital. Started Jul 2023; status: recruiting.

02

Drugs

Jinsang Liyan Capsule
03

Conditions

laryngopharyngeal reflux (LPR)

Beyond the preview

Go deeper on NCT05879029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05879029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call